Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice

Journal of Neuroscience

Volumn 18, Issue 10, 1998, Pages 3639-3649

  Brandon, Eugene P ^a   Logue, Sheree F ^b   Adams, Monique R ^a   Qi, Ming ^a   Sullivan, Sean P ^a   Matsumoto, Alvin M ^a   Dorsa, Daniel M ^a   Wehner, Jeanne M ^b   McKnight, G Stanley ^a   Idzerda, Rejean L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Amphetamine; cAMP dependent protein kinase; Dopamine; Dynorphin; Fos; Knockout; Locomotion; Mouse; PKA; Rotarod; Se nsitization; Striatum

Indexed keywords

AMPHETAMINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; DYNORPHIN; GENE PRODUCT; MESSENGER RNA; PROTEIN C FOS;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME DEFICIENCY; GENE EXPRESSION REGULATION; LOCOMOTION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL;

EID: 0032525114     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-10-03639.1998     Document Type: Article

References (74)

1. Accili D, Fishburn CS, Drago J, Steiner H, Lachowicz JE, Park BH, Gauda EB, Lee EJ, Cool MH, Sibley DR, Gerten CR, Westphal H, Fuchs S (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc Natl Acad Sci USA 93:1945-1949.
2. Adams MR, Brandon EP, Chartoff EH, Idzerda RL, Dorsa DM, McKnight GS (1997) Loss of haloperidol-induced gene expression and catalepsy in protein kinase A-deficient mice. Proc Natl Acad Sci USA 94:12157-12161.
3. Albin RL, Young AB, Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
4. Amieux PS, Cummings DE, Motamed K, Brandon EP, Wailes LA, Le K, Idzerda RL, McKnight GS (1997) Compensatory regulation of RIα protein levels in protein kinase A mutant mice. J Biol Chem 272:3993-3998.
5. Angulo JA, McEwen BS (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Rev 19:1-28.
6. Bacskai BJ, Hochner B, Mahaut SM, Adams SR, Kaang BK, Kandel ER, Tsien RY (1993) Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia sensory neurons. Science 260:222-226.
7. Baik JH, Picetti R, Saiardi A, Thiriet G, Dierich A, Depaulis A, Le Meur M, Borrelli E (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377:424-428.
8. Bargas J, Galarraga E (1995) Firing response modulation in neostriatal projection neurons by cholinergic and dopaminergic agonists. In: Molecular and cellular mechanisms of neostriatal function (Ariano MA, Surmeier DJ, eds), pp 183-191. Austin, TX: Landes.
9. Bertolucci DM, Serrano A, Scatton B (1990) Differential effects of forced locomotion, tail-pinch, immobilization, and methyl-beta-carboline carboxylate on extracellular 3,4-dihydroxyphenylacetic acid levels in the rat striatum, nucleus accumbens, and prefrontal cortex: an in vivo voltammetric study. J Neurochem 55:1208-1215.
10. 2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87:1203-1214.
11. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219.
12. Brandon EP, Gerhold KA, Oi M, McKnight GS, Idzerda RL (1995a) Derivation of novel embryonic stem cell lines and targeting of cyclic AMP-dependent protein kinase genes. Recent Prog Horm Res 50:403-408.
13. Brandon EP, Zhuo M, Huang YY, Qi M, Gerhold KA, Burton KA, Kandcl ER, McKnight GS, Idzerda RL (1995b) Hippoeampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RIβ subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 92:8851-8855.
14. Cadd G, McKnight GS (1989) Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain. Neuron 3:71-79.
15. Cadd GG, Uhler MD, McKnight GS (1990) Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides. J Biol Chem 265:19502-19506.
16. Camp DM, Browman KE, Robinson TE (1994) The effects of methamphetamine and cocaine on motor behavior and extracellular dopamine in the ventral striatum of Lewis versus Fischer 344 rats. Brain Res 668:180-193.
17. Capecchi MR (1989) Altering the genome by homologous recombination. Science 244:1288-1292.
18. Clegg CH, Correll LA, Cadd GG, McKnight GS (1987) Inhibition of imracellular cAMP-dependent protein kinase using mutant genes of the regulatory type I subunit. J Biol Chem 262:13111-13119.
19. Cole RL, Konradi C, Douglass J, Hyman SE (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14:813-823.
20. Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419-436.
21. Cummings DE, Brandon EP, Planas JA, Motamed K, Idzerda RL, McKnight GS (1996) Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A. Nature 382:622-626.
22. DeLong M (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
23. Douglass J, McKinzie AA, Pollock KM (1994) Identification of multiple DNA elements regulating basal and protein kinase A-induced transcriptional expression of the rat prodynorphin gene. Mol Endocrinol 8:333-344.
24. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ, Huang SP, Bartlett PF, Jose PA, Sibley DR, Westphal H (1994) Altered striatal function in a mutant mouse lacking DIA dopamine receptors. Proc Natl Acad Sci USA 91:12564-12568.
25. Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46:208-209.
26. Emerich DF, McDermott PE, Krueger PM, Frydel B, Sanberg PR, Winn SR (1993) Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats. Exp Neurol 122:37-47.
27. Faux MC, Scott JD (1996) Molecular glue: kinase anchoring and scaffold proteins. Cell 85:9-12.
28. Gage FH, Dunnett SB, Stenevi U, Bjorklund A (1983) Aged rats: recovery of motor impairments by intrastriatal nigral grafts. Science 221:966-969.
29. Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139.
30. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJJ, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
31. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
32. Glantz SB, Amat JA, Rubin CS (1992) cAMP signaling in neurons: patterns of neuronal expression and intracellular localization for a novel protein, AKAP 150, that anchors the regulatory subunit of cAMP-dependent protein kinase II beta. Mol Biol Cell 3:1215-1228.
33. Goelet P, Castellucci VF, Schacher S, Kandel ER (1986) The long and the short of long-term memory - a molecular framework. Nature 322:419-422.
34. 3H]-dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856.
35. Graybiel AM (1990) Neurotransmitters and neuromoclulators in the basal ganglia. Trends Neurosci 13:244-254.
36. Greif GJ, Lin YJ, Liu JC, Freedman JE (1995) Dopamine-modulated potassium channels on rat striatal neurons: specific activation and cellular expression. J Neurosci 15:4533-4544.
37. Groves PM, Rebec GV (1976) Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Annu Rev Psychol 27:91-127.
38. Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenbcrg TS (1995) Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. J Pharmacol Exp Ther 275:150-163.
39. Hersch SM, Ciliax BJ, Gutekunst CA, Rees HD, Heilman CJ, Yung KK, Bolam JP, Ince E, Yi H, Levey AI (1995) Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237.
40. Jaber M, Cador M, Dumartin B, Normand E, Stinus L, Bloch B (1995) Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 65:1041-1050.
41. Jahnsen T, Hedin L, Lohmann SM, Walter U, Richards JS (1986) The neural type II regulatory subunit of cAMP-dependent protein kinase is present and regulated by hormones in the rat ovary. J Biol Chem 261:6637-6639.
42. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
43. Karler R, Finnegan KT, Calder LD (1993) Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res 603:19-24.
44. Koob GF, Stinus L, Le Moal M (1981) Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav Brain Res 3:341-359.
45. Lalonde R, Bensoula AN, Filali M (1995) Rotarod sensorimotor learning in cerebellar mutant mice. Neurosci Res 22:423-426.
46. Liebmann JE, Matsumoto AM (1990) Acute selective withdrawal of testosterone negative feedback increases luteinizing hormone secretion without altering hypothalamic catecholaminergic neuronal activity. Endocrinology 126:555-564.
47. Liu FC, Graybiel AM (1996) Spatiotemporal dynamics of CREB phosphorylation; transient versus sustained phosphorylation in the developing striatum. Neuron 17:1133-1144.
48. Ludvig N, Ribak CE, Scott JD, Rubin CS (1990) Immunocytochemical localization of the neural-specific regulatory subunit of the type II cyclic AMP-dependent protein kinase to postsynaptic structures in the rat brain. Brain Res 520:90-102.
49. McMillen BA (1983) CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol Sci 4:429-432.
50. Miserendino MJ, Nestler EJ (1995) Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 674:299-306.
51. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, Wignall JM, Smith C, Gallis B, Sims JE, Urdal D, Widmer MB, Cosman D, Park LS (1989) The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335-348.
52. Oyen O, Eskild W, Beebe SJ, Hansson V, Jahnsen T (1988) Biphasic response to 3′,5′-cyclic adenosine monophosphate (cAMP) at the messenger ribonucleic acid level for a regulatory subunit of cAMP-dependent protein kinase. Mol Endocrinol 2:1070-1076.
53. Pauly JR, Robinson SF, Collins AC (1993) Chronic corticosteronc administration enhances behavioral sensitization to amphetamine in mice. Brain Res 620:195-202.
54. Picetti R, Saiardi A, Samad TA, Bozzi Y, Baik J-H, Borrelli E (1997) Dopamine D2 receptors in signal transduction and behavior. Crit Rev Neurobiol 11:121-142.
55. Robinson TE, Becker JB (1906) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and eval- uation of animal models of amphetamine psychosis. Brain Res 396:157-198.
56. Rosenmund C, Carr DW, Bergeson SE, Nilaver G, Scott JD, Westbrook GL (1994) Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 368:853-856.
57. Rubin CS (1994) A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim Biophys Acta 1224:467-479.
58. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK (1997) Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001.
59. Sassone-Corsi P, Visvader J, Ferland L, Mellon PL, Verma IM (1988) Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev 2:1529-1538.
60. Sheng M, McFadden G, Greenberg ME (1990) Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4:571-582.
61. Steiner H, Gerfen CR (1993) Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 13:5066-5081.
62. Stoof JC, Kebabian JW (1981) Opposing roles for D1 and D2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294:366-368.
63. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
64. Surmeier DJ, Cantrell AR, Carter-Russell H (1995) Dopaminergic and cholinergic modulation of calcium conductances in neostriatal neurons. In: Molecular and cellular mechanisms of neostriatal function (Ariano MA, Surmeier DJ, eds), pp 193-215. Austin, TX: Landes.
65. Surmeier DJ, Song WJ, Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.
66. Thompson LA, Matsumoto RR, Hohmann AG, Walker JM (1990) Striatonigral prodynorphin: a model system for understanding opioid peptide function. Ann NY Acad Sci 579:192-203.
67. Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S (1989) Effects of selective D1 and D2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 98:89-92.
68. Vezina P, Stewart J (1989) The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499:108-120.
69. Walsh SL, Wagner GC (1992) Motor impairments after methamphetamine-induced neurotoxicity in the rat. J Pharmacol Exp Ther 263:617-626.
70. Wang JQ, Smith AJ, McGinty JF (1995) A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268, and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience 68:83-95.
71. Ward RP, Dorsa DM (1996) Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J Comp Neurol 370:405-414.
72. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S (1994a) Elimination of cocaine-induced hyperactivity and dopamine-mediated neuropliysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955.
73. Xu M, Moratalla R, Gold LH, Hiroi N, Kooh GF, Graybiel AM, Tonegawa S (1994b) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79:729-742.
74. Zhou QY, Palmiter RD (1995) Dopamine-defieient mice are severely hypuactive, adipsie, and aphagic. Cell 83:1197-1209.